- Home
- EYPT vs DGICA Comparison
EYPT vs DGICA Comparison
Compare EYPT & DGICA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EYPT
- DGICA
- Stock Information
- Founded
- EYPT 1987
- DGICA 1986
- Country
- EYPT United States
- DGICA United States
- Employees
- EYPT N/A
- DGICA N/A
- Industry
- EYPT Biotechnology: Laboratory Analytical Instruments
- DGICA Property-Casualty Insurers
- Sector
- EYPT Industrials
- DGICA Finance
- Exchange
- EYPT Nasdaq
- DGICA Nasdaq
- Market Cap
- EYPT 579.4M
- DGICA 683.3M
- IPO Year
- EYPT 2005
- DGICA N/A
- Fundamental
- Price
- EYPT $10.48
- DGICA $17.36
- Analyst Decision
- EYPT Strong Buy
- DGICA Hold
- Analyst Count
- EYPT 8
- DGICA 1
- Target Price
- EYPT $24.75
- DGICA $18.00
- AVG Volume (30 Days)
- EYPT 729.0K
- DGICA 171.9K
- Earning Date
- EYPT 08-06-2025
- DGICA 07-24-2025
- Dividend Yield
- EYPT N/A
- DGICA 4.20%
- EPS Growth
- EYPT N/A
- DGICA 965.80
- EPS
- EYPT N/A
- DGICA 2.34
- Revenue
- EYPT $56,042,000.00
- DGICA $993,645,050.00
- Revenue This Year
- EYPT N/A
- DGICA $3.27
- Revenue Next Year
- EYPT N/A
- DGICA $5.19
- P/E Ratio
- EYPT N/A
- DGICA $7.42
- Revenue Growth
- EYPT 12.04
- DGICA 3.36
- 52 Week Low
- EYPT $3.91
- DGICA $13.35
- 52 Week High
- EYPT $13.99
- DGICA $21.12
- Technical
- Relative Strength Index (RSI)
- EYPT 59.34
- DGICA 31.12
- Support Level
- EYPT $10.26
- DGICA $18.17
- Resistance Level
- EYPT $11.00
- DGICA $18.69
- Average True Range (ATR)
- EYPT 0.64
- DGICA 0.47
- MACD
- EYPT -0.07
- DGICA -0.11
- Stochastic Oscillator
- EYPT 42.11
- DGICA 9.31
About EYPT EyePoint Pharmaceuticals Inc.
EyePoint Pharmaceuticals Inc is a pharmaceutical company. It is engaged in developing and commercializing ophthalmic products for the treatment of eye diseases. The company has developed FDA-approved sustained-release treatments in ophthalmology. Its pre-clinical development program is focused on using its core Durasert E and Verisome technology platforms to deliver drugs to treat wet age-related macular degeneration, glaucoma, osteoarthritis, and other diseases. Geographically, the firm has operational footprints in the U.S., China, and the UK. It generates a majority of its revenue from the U.S.
About DGICA Donegal Group Inc.
Donegal Group Inc is an insurance holding company that offers businesses and individuals personal and commercial lines of property and casualty insurance. The company's reportable segments are its Investment function, Personal lines of insurance, and Commercial lines of insurance. Personal lines products consist mainly of homeowners and private passenger automobile policies. The Commercial lines products of its insurance subsidiaries consist mainly of commercial automobile, commercial multi-peril, and workers' compensation policies. The group mainly operates in the United States.